Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Immunocore

    NASDAQ: IMCR · Real-Time Price · USD
    32.63
    -2.05 (-5.91%)
    At close: Jun 16, 2025, 3:59 PM
    32.91
    0.86%
    After-hours: Jun 16, 2025, 04:04 PM EDT

    Immunocore Statistics

    Share Statistics

    Immunocore has 50.18M shares outstanding. The number of shares has increased by 0.12% in one year.

    Shares Outstanding

    n/a
    		 50.18M

    Shares Change (YoY)

    n/a
    		 0.12%

    Shares Change (QoQ)

    n/a
    		 0.08%

    Owned by Institutions (%)

    n/a
    		 91.95%

    Shares Floating

    n/a
    		 48.62M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,206

    FTD / Avg. Volume

    n/a
    		 0.28%

    Short Selling Information

    The latest short interest is 8.01M, so 15.95% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 8.01M

    Short % of Shares Out

    n/a
    		 15.95%

    Short % of Float

    n/a
    		 21.99%

    Short Ratio (days to cover)

    n/a
    		 14.96

    Valuation Ratios

    The PE ratio is -28.87 and the forward PE ratio is -33.98. Immunocore's PEG ratio is 2.97.

    PE Ratio

    n/a
    		 -28.87

    Forward PE

    n/a
    		 -33.98

    PS Ratio

    n/a
    		 4.75

    Forward PS

    n/a
    		 1.9

    PB Ratio

    n/a
    		 4.09

    P/FCF Ratio

    n/a
    		 70.6

    PEG Ratio

    n/a
    		 2.97
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Immunocore.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.38, with a Debt / Equity ratio of 1.2.

    Current Ratio

    n/a
    		 4.38

    Quick Ratio

    n/a
    		 4.36

    Debt / Equity

    n/a
    		 1.2

    Debt / EBITDA

    n/a
    		 -6.14

    Debt / FCF

    n/a
    		 20.72

    Interest Coverage

    n/a
    		 -3.74

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $629,212.98

    Profits Per Employee

    n/a
    		 $-103,624.75

    Employee Count

    n/a
    		 493

    Asset Turnover

    n/a
    		 0.31

    Inventory Turnover

    n/a
    		 0.5

    Taxes

    Income Tax

    n/a
    		 -1.85M

    Effective Tax Rate

    n/a
    		 3.49%

    Stock Price Statistics

    The stock price has increased by -11.79% in the last 52 weeks. The beta is 0.83, so Immunocore's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.83

    52-Week Price Change

    n/a
    		 -11.79%

    50-Day Moving Average

    n/a
    		 31.08

    200-Day Moving Average

    n/a
    		 31.16

    Relative Strength Index (RSI)

    n/a
    		 46.15

    Average Volume (20 Days)

    n/a
    		 432,087

    Income Statement

    In the last 12 months, Immunocore had revenue of 310.2M and earned -51.09M in profits. Earnings per share was -1.02.

    Revenue

    n/a
    		 310.2M

    Gross Profit

    n/a
    		 307.47M

    Operating Income

    n/a
    		 -70.46M

    Net Income

    n/a
    		 -51.09M

    EBITDA

    n/a
    		 -70.46M

    EBIT

    n/a
    		 -71.78M

    Earnings Per Share (EPS)

    n/a
    		 -1.02
    Full Income Statement

    Balance Sheet

    The company has 455.73M in cash and 432.72M in debt, giving a net cash position of 23.01M.

    Cash & Cash Equivalents

    n/a
    		 455.73M

    Total Debt

    n/a
    		 432.72M

    Net Cash

    n/a
    		 23.01M

    Retained Earnings

    n/a
    		 -795.76M

    Total Assets

    n/a
    		 1.03B

    Working Capital

    n/a
    		 799.46M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 26.06M and capital expenditures -5.17M, giving a free cash flow of 20.89M.

    Operating Cash Flow

    n/a
    		 26.06M

    Capital Expenditures

    n/a
    		 -5.17M

    Free Cash Flow

    n/a
    		 20.89M

    FCF Per Share

    n/a
    		 0.42
    Full Cash Flow Statement

    Margins

    Gross margin is 99.12%, with operating and profit margins of -22.71% and -16.47%.

    Gross Margin

    n/a
    		 99.12%

    Operating Margin

    n/a
    		 -22.71%

    Pretax Margin

    n/a
    		 -17.07%

    Profit Margin

    n/a
    		 -16.47%

    EBITDA Margin

    n/a
    		 -22.71%

    EBIT Margin

    n/a
    		 -22.71%

    FCF Margin

    n/a
    		 6.73%

    Dividends & Yields

    IMCR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IMCR is $66, which is 102.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $66

    Price Target Difference

    n/a
    		 102.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 16
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 1.5

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist